Top compounds associated with response to NLGN2


Feature Type Standardized
Nominal ANOVA
mRNA Sildenafil CTRPv2 pan-cancer AAC 0.00042 1
mRNA GDC-0941 gCSI pan-cancer AAC -0.00068 1
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.00012 1
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -9.6e-05 1
Download CSV